Multivalent Vaccine for Tenacibaculum and Moritella Infections

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current vaccines and diagnostic tools are inadequate for effectively preventing and diagnosing tenacibaculosis in farmed fish, as they do not account for the role of Tenacibaculum species in causing ulcers, leading to ongoing financial losses and ethical concerns in aquaculture.

Innovation Solution

A novel Tenacibaculum isolate is identified and characterized, which can induce tenacibaculosis in challenge studies, and specific nucleic acid sequences are provided for developing vaccines and diagnostic methods to detect Tenacibaculum infections, distinguishing them from Moritella viscosa infections.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If current vaccines targeting Moritella viscosa are used, then protection against winter ulcer is provided, but outbreaks of winter ulcer still occur because the vaccines do not account for Tenacibaculum species involvement

Engineering Contradiction:
Improvevaccine effectivenessVSAvoidpathogen coverage
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent develops a multivalent vaccine composition that combines antigens from both Moritella viscosa and Tenacibaculum species, enabling the vaccine to protect against multiple pathogens simultaneously. This resolves the contradiction by making the vaccine universally effective against different causative agents of ulcerative diseases while maintaining its protective function.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The vaccine composition is segmented into distinct antigen components from different bacterial species (Moritella viscosa and Tenacibaculum), allowing each pathogen-specific antigen to function independently. This segmentation enables the vaccine to address multiple pathogens without compromising the effectiveness against each individual pathogen.

Inventive Principle:
Principle #1Segmentation

2Measurement precision

If diagnostic tools are developed based on Moritella viscosa only, then detection of winter ulcer cases is enabled, but accurate differentiation from Tenacibaculum infections cannot be achieved

Engineering Contradiction:
Improvepathogen detection accuracyVSAvoidpathogen discrimination capability
Core Design Contradiction:
Measurement precisionVSAdaptability or versatility

Solution Approach 1:

The diagnostic system uses segmented, pathogen-specific nucleic acid sequences and antibodies that target either Moritella viscosa or Tenacibaculum species specifically. This allows the diagnostic tool to accurately detect and differentiate between the two pathogens, resolving the contradiction by enabling precise measurement of each pathogen's presence independently.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces pathogen-specific nucleic acid sequences and antibodies as intermediary markers that mediate between the sample and the detection system. These intermediaries provide specific binding to either Moritella viscosa or Tenacibaculum, enabling accurate differentiation and resolution of the diagnostic contradiction.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Ease of manufacture

If continued use of single-pathogen vaccines is maintained, then manufacturing simplicity is preserved, but ongoing financial losses from ineffective vaccination occur

Engineering Contradiction:
Improvevaccine production complexityVSAvoideconomic loss
Core Design Contradiction:
Ease of manufactureVSLoss of energy

Solution Approach 1:

The patent merges multiple antigen components from different bacterial species into a single multivalent vaccine composition. This combining approach maintains manufacturing efficiency by producing one integrated vaccine product rather than multiple separate vaccines, while simultaneously improving effectiveness to prevent economic losses from vaccine failure.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The multivalent vaccine composition provides universal protection against multiple pathogens that cause ulcerative diseases. This multi-functionality resolves the contradiction by enabling a single vaccine product to address several pathogens, maintaining manufacturing simplicity while improving economic outcomes through effective disease prevention.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentEP3155088B1Novel tenacibaculum sp isolate
Publication Date: 2020.08.05 CERMAQ GRP AS
  • EP3155088B1 patent drawingFigure 1
  • EP3155088B1 patent drawingFigure 2
  • EP3155088B1 patent drawingFigure 3

AI summary

The present invention relates to a novel fish pathogen, in particular a novel Tenacibaculum specie involved in the development of tenacibaculosis in farmed fish. More particularly, the present invention relates to a vaccine useful in providing protection against tenacibaculosis as well as the development of ulcers associated with Tenacibaculum infections in farmed fish. The present invention furthermore provides DNA sequences and oligonucleotide sequences useful in diagnostic assays etc.